TY - JOUR T1 - Effects of cattle on vector-borne disease risk to humans: A systematic review JF - medRxiv DO - 10.1101/2023.02.08.23285683 SP - 2023.02.08.23285683 AU - Sulagna Chakraborty AU - Siyu Gao AU - Brian. F Allan AU - Rebecca Lee Smith Y1 - 2023/01/01 UR - http://medrxiv.org/content/early/2023/02/09/2023.02.08.23285683.abstract N2 - Vector-borne diseases (VBDs) may be transmitted among humans, domestic animals, and wildlife, with cattle in particular serving as an important source of exposure risk to humans. The close associations between humans and cattle can facilitate transmission of numerous VBDs which can impact nations’ public health and economic security. Published studies demonstrate that cattle can influence human exposure risk positively, negatively or have no effect. There is a critical need to synthesize the information in the scientific literature on this subject, in order to illuminate the various ecological mechanisms that can affect the risk of humans contracting VBDs from cattle. Therefore, the aim of this systematic review was to review the scientific literature, provide a synthesis of the possible effects of cattle on VBD risk to humans, and propose future directions for research. This study was performed according to the PRISMA 2020 extension guidelines for systematic review. After screening 470 peer-reviewed articles published between 1999 – 2019 using the databases Web of Science Core Collection, PubMed Central, CABI Global Health, and Google Scholar, and utilizing forward and backward search techniques, we identified 127 papers that met inclusion criteria. Results of the systematic review indicate that cattle can be beneficial or harmful to human health with respect to VBDs depending on vector and pathogen ecology and livestock management practices. Cattle can increase risk of exposure to infections transmitted by tsetse flies and ticks, followed by sandflies and mosquitoes, through a variety of mechanisms. However, cattle can have a protective effect when the vector prefers to feed on cattle instead of humans and when chemical control measures (e.g., acaricides/insecticides), semio-chemicals, and other integrated vector control measures are utilized in the community. We highlight that further research is needed to determine ways in which these mechanisms may be exploited to reduce VBD risk in humans.Author Summary Vector-borne diseases (VBDs) are caused by infections transmitted by blood-feeding arthropods from an infected to an uninfected organism. These infections may be caused by pathogenic bacteria, viruses, or protozoans and arthropods may transmit these infections to humans, domestic animals, and wildlife. Humans and cattle spend a significant amount of time in close proximity with each other through various activities such as agriculture, animal husbandry, trading, and animal farming, which can potentially increase risk to human health. Previously published studies indicated cattle can impact VBD transmission both positively and negatively, however, there has not been a recent synthesis of the scientific literature on this subject. Through this global systematic review of the scientific literature, we found that cattle could have either harmful or beneficial impacts on human health when it comes to VBDs, but most often increase exposure risk to VBDs in humans. We identified various mechanisms from the scientific literature by which cattle can impact VBD risk in humans. Further research is needed to better understand specific ecological mechanisms by which cattle impact human health and develop measures that will prevent and reduce VBD exposure risk in humans.Competing Interest StatementThe authors have declared no competing interest.Funding StatementFunding: This work is supported by the USDA National Institute of Food and Agriculture, Hatch project 1026333 (ILLU-875-984) and the Sharon Gray Memorial Award from the School of Integrative Biology at the University of Illinois Urbana-Champaign (UIUC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study is a systematic review and did not involve research with human subjects or animal subjects, hence did not require an IRB approval.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesS1 Appendix in the supporting information section lists the final pool of included studies that we obtained after performing the article search on databases and screening them against our inclusion and exclusion criteria. This appendix has the names of the papers, author, publication year, country of publication, vector taxa, study implication and database source. ER -